Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pilot Study of TENS for Ocular Pain

NCT: NCT05531643 · COMPLETED

NCT IDNCT05531643
StatusCOMPLETED
Start Date2022-10-03
Completion2024-11-30
SponsorVA Office of Research and Development (FED)
First posted
Last updated

Brief Summary

Approximately 20% of Veterans have a diagnosis of dry eye (DE) syndrome which is often accompanied by ocular pain that significantly impacts activities of daily living. Currently very few treatments are available for chronic ocular pain, likely because the mechanisms underlying this type of pain have only recently begun to be studied. New treatments that target the neuropathic mechanisms contributing to this type of pain are needed. The proposed research provides a crucial step in addressing the lack of treatments for neuropathic ocular pain by validating the methodology needed to support a randomized controlled trial of transcutaneous electrical nerve stimulation (TENS). TENS is a non-pharmacologic, non-addictive, non-invasive treatment that has been shown to be effective in other chronic pain conditions. The present pilot study aims to address the need for preliminary support of safety and efficacy of TENS for ocular pain, t to advance the study of new treatments for the long-term relief of chronic ocular pain and its impact on health.

Frequently Asked Questions

What is Pilot Study of TENS for Ocular Pain?

Pilot Study of TENS for Ocular Pain is a clinical trial registered under NCT05531643. Current status: COMPLETED.

What is the status of NCT05531643?

The current status of NCT05531643 (Pilot Study of TENS for Ocular Pain) is: COMPLETED.

When did Pilot Study of TENS for Ocular Pain start?

Pilot Study of TENS for Ocular Pain started on 2022-10-03.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.